experimental group:Sintilimab in combination with Multimodality Radiotherapy

2 trials

Sponsors

West China Hospital of Sichuan University

Conditions

Primary hepatocellular carcinoma

Phase 2

Efficacy and safety of Sintilimab in combination with Multimodality Radiotherapy in advanced metastatic primary hepatocellular carcinoma treated with multiline therapy: a phase II clinical study

RecruitingChiCTR2100045674

West China Hospital of Sichuan UniversityPrimary hepatocellular carcinoma

Start: 2021-05-01Updated: 2021-12-06

Efficacy and safety of Sintilimab in combination with Multimodality Radiotherapy in advanced metastatic primary hepatocellular carcinoma treated with multiline therapy: a phase II clinical study

RecruitingChiCTR2100046895

West China Hospital of Sichuan UniversityPrimary hepatocellular carcinoma

Start: 2021-06-01Updated: 2022-01-10